Related Experiment Video
Updated: Jul 15, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia
K Govind Babu1, Venkata Satya Suresh Attili, P P Bapsy
1Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, 560 029, India.
International Ophthalmology
|April 6, 2007
Abstract:
Imatinib is presently the commonest prescribes drug for patients of chronic myelogenous leukemia (CML) in chronic phase (CP) worldwide. Its ocular side effects are little known. Optic neuritis caused by this drug has not been reported (Medline search). We describe perhaps the first case of optic neuritis caused by this drug.
